IL34 and ovarian cancer: It has been reported that social, genetic, and histopathological factors, as well as some new mutations (titin mutation, BAIAP3, IL34, WNT10A, NEU1, SLC44A4, HMOX1, TCN2, PES1, RP1-56J10.8, ABR, NCAM1, RP11-629G13.1, AC006372.4, and NPTXR in BOTS and hgOvCa, etc.)are associated with ovarian cancer survival and mortality [26,27].